Paul Workman

1.6k total citations
5 papers, 483 citations indexed

About

Paul Workman is a scholar working on Organic Chemistry, Molecular Biology and Cell Biology. According to data from OpenAlex, Paul Workman has authored 5 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Cell Biology. Recurrent topics in Paul Workman's work include Innovative Microfluidic and Catalytic Techniques Innovation (1 paper), Autophagy in Disease and Therapy (1 paper) and Ferrocene Chemistry and Applications (1 paper). Paul Workman is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (1 paper), Autophagy in Disease and Therapy (1 paper) and Ferrocene Chemistry and Applications (1 paper). Paul Workman collaborates with scholars based in United Kingdom, Japan and United States. Paul Workman's co-authors include Peter J. Parker, Masahiko Hayakawa, Takahide Ohishi, Michael D. Waterfield, Hiroyuki Kaizawa, Tomonobu Koizumi, Frank T. Cooke, Parmjit Jat, Harold B.J. Jefferies and Shin‐ichi Tsukamoto and has published in prestigious journals such as Nature Chemical Biology, Biochemical Pharmacology and EMBO Reports.

In The Last Decade

Paul Workman

5 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Workman United Kingdom	5	279	159	81	65	64	5	483
Hiroyuki Kaizawa Japan	9	470 1.7×	184 1.2×	96 1.2×	79 1.2×	77 1.2×	9	803
Dale Corkery Sweden	13	297 1.1×	113 0.7×	28 0.3×	70 1.1×	63 1.0×	28	508
Bertal H. Aktas United States	19	509 1.8×	192 1.2×	25 0.3×	101 1.6×	74 1.2×	33	781
M. Welin Sweden	13	363 1.3×	41 0.3×	27 0.3×	53 0.8×	84 1.3×	30	551
Alison J. Inglis United Kingdom	10	592 2.1×	236 1.5×	36 0.4×	38 0.6×	37 0.6×	11	744
N S Datta United States	8	346 1.2×	63 0.4×	71 0.9×	54 0.8×	113 1.8×	12	546
Shawn M. Vogen United States	13	402 1.4×	130 0.8×	24 0.3×	49 0.8×	46 0.7×	14	549
Carrow I. Wells United States	18	566 2.0×	160 1.0×	17 0.2×	40 0.6×	187 2.9×	46	843
Gillian L. Dornan Canada	11	450 1.6×	120 0.8×	39 0.5×	36 0.6×	48 0.8×	15	599
Slavica Brnjic Sweden	11	686 2.5×	138 0.9×	27 0.3×	167 2.6×	258 4.0×	15	854

Countries citing papers authored by Paul Workman

Since Specialization

Citations

This map shows the geographic impact of Paul Workman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Workman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Workman more than expected).

Fields of papers citing papers by Paul Workman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Workman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Workman. The network helps show where Paul Workman may publish in the future.

Co-authorship network of co-authors of Paul Workman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Workman. A scholar is included among the top collaborators of Paul Workman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Workman. Paul Workman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Knapp, Stefan, Paulo Arruda, S.K. Burley, et al.. (2012). A public-private partnership to unlock the untargeted kinome. Nature Chemical Biology. 9(1). 3–6. 108 indexed citations

2.

Hayward, Daniel, Yvette Newbatt, Lisa Pickard, et al.. (2010). Identification by High-Throughput Screening of Viridin Analogs as Biochemical and Cell-Based Inhibitors of the Cell Cycle–Regulated Nek2 Kinase. SLAS DISCOVERY. 15(8). 918–927. 29 indexed citations

3.

Jefferies, Harold B.J., Frank T. Cooke, Parmjit Jat, et al.. (2008). A selective PIKfyve inhibitor blocks PtdIns(3,5)P ₂ production and disrupts endomembrane transport and retroviral budding. EMBO Reports. 9(2). 164–170. 228 indexed citations

4.

Hayakawa, Masahiko, Kenichi Kawaguchi, Hiroyuki Kaizawa, et al.. (2007). Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110α inhibitors. Bioorganic & Medicinal Chemistry. 15(17). 5837–5844. 109 indexed citations

5.

Hartmann, Niklas, et al.. (1990). Doxorubicin-3′-NH-oestrone-17-oxime-ethyl-carbonyl, a doxorubicin-oestrone conjugate that does not redox cycle in rat liver microsomes. Biochemical Pharmacology. 40(5). 1164–1167. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact